2400 mg/ m2) daglig i 5 dage til 5 voksne patienter og op til 2900 mg/ m2 til yderligere 2 voksne på dag 1, 3 og 5.
Nelarabine has been administered in clinical trials up to a dose of 75 mg/ kg (approximately 2,250 mg/ m2) daily for 5 days to a paediatric patient, up to a dose of 60 mg/ kg (approximately 2,400 mg/ m2) daily for 5 days to 5 adult patients and up to 2,900 mg/ m2 in a further 2 adults on days 1, 3 and 5.